Over-the-counter ranitidine drugs including Zantac and generic versions were pulled from the shelves in October 2019 following the discovery of high levels of a probable carcinogen called NDMA in tested samples. In April 2020, the ranitidine recall was expanded and ranitidine prescription and OTC products are no longer available in the United States due to the risk of serious side effects, organ damage, and cancer.
If you have taken ranitidine products in the past, including prescription and over-the-counter Zantac, it’s important to understand ranitidine side effects and risks. You may be eligible to file a Zantac lawsuit against the manufacturer if you have been diagnosed with cancer or suffered serious harm.
If you took Zantac and have been diagnosed with cancer or other serious conditions, schedule a free and confidential initial consultation with our experienced and compassionate legal team at SteinLaw to get the compensation you deserve.
